← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS · Approved 2018-03-05

Drug application

FDA Application #

ANDA204880

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

Oxaliplatin

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ACTAVIS

First approval

2018-03-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown